Robert Whitaker on February 23, 2012
Recently, Robert Gibbons published a paper in which he claimed, based on his "reanalysis" of the data from studies of fluoxetine in youth, that "treatment with fluoxetine was not found to be related to suicide risk when compared with placebo." David Healy responded, with a reference to new data from the NIMH's Treatment for Adolescents with Depression Study (TADS).
Recently, Robert Gibbons published a paper in which he claimed, based on his "reanalysis" of the data from studies of fluoxetine in youth, that "treatment with fluoxetine was not found to be related to suicide risk when compared with placebo." David Healy responded, with a reference to new data from the NIMH's Treatment for Adolescents with Depression Study (TADS).
Verified by Psychology Today
